Stock listing
Contineum Therapeutics, Inc.
Selected listing: CTNM · NASDAQ · USD · US
Contineum Therapeutics, Inc. (NASDAQ:CTNM), Health Technology. Latest release Sep 14, 2026: Contineum Therapeutics Reports Phase 2 Results…
- Ticker
- NASDAQ:CTNM
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Contineum Therapeutics, Inc.
The company focuses on developing innovative therapeutic solutions. As a publicly traded entity, CTNM is listed on the American stock market, providing investors with opportunities to engage in its growth and development.
Latest news from Contineum Therapeutics, Inc.
Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder
September 14, 2026
Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference
August 25, 2026
Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones
July 30, 2026
Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference
June 1, 2026
Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference
May 12, 2026
Research Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc. company profile
View the public company page for Contineum Therapeutics, Inc. on 6ix.
Contineum Therapeutics, Inc. news
Read company news and market updates connected to Contineum Therapeutics, Inc..
Contineum Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Contineum Therapeutics, Inc..